Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Oncological Medicine
Volume 2015, Article ID 626741, 5 pages
http://dx.doi.org/10.1155/2015/626741
Case Report

Successful Intravascular Correction of Intratumoral Pseudoaneurysm by Erosion of the Aorta in a Patient with Thoracic Giant Cell Tumor of Bone Responding to Denosumab

1Instituto do Câncer do Estado de São Paulo, Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brazil
2Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brazil

Received 5 June 2015; Accepted 13 October 2015

Academic Editor: Francesco A. Mauri

Copyright © 2015 Natalia M. P. Fraile et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Gong, W. Liu, X. Sun et al., “Histological and clinical characteristics of malignant giant cell tumor of bone,” Virchows Archiv, vol. 460, no. 3, pp. 327–334, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. L. van der Heijden, P. Sander Dijkstra, M. A. J. van de Sande et al., “The clinical approach toward giant cell tumor of bone,” Oncologist, vol. 19, no. 5, pp. 550–561, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Campanacci, N. Baldini, S. Boriani, and A. Sudanese, “Giant-cell tumor of bone,” The Journal of Bone & Joint Surgery—American Volume, vol. 69, no. 1, pp. 106–114, 1987. View at Google Scholar · View at Scopus
  4. D. Thomas, R. Henshaw, K. Skubitz et al., “Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study,” The Lancet Oncology, vol. 11, no. 3, pp. 275–280, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Chawla, R. Henshaw, L. Seeger et al., “Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study,” The Lancet Oncology, vol. 14, no. 9, pp. 901–908, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. T. Ueda, H. Morioka, Y. Nishida et al., “Objective tumor response to denosumab in patients with giant cell tumor of bone: a multicenter phase II trial,” Annals of Oncology, vol. 26, no. 10, pp. 2149–2154, 2015. View at Publisher · View at Google Scholar
  7. J. Martin-Broto, C. S. Cleeland, P. A. Glare et al., “Effects of denosumab on pain and analgesic use in giant cell tumor of bone: interim results from a phase II study,” Acta Oncologica, vol. 53, no. 9, pp. 1173–1179, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Alberghini, K. Kliskey, T. Krenacs et al., “Morphological and immunophenotypic features of primary and metastatic giant cell tumour of bone,” Virchows Archiv, vol. 456, no. 1, pp. 97–103, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. N. A. Karras, L. E. Polgreen, C. Ogilvie, J. C. Manivel, K. M. Skubitz, and E. Lipsitz, “Denosumab treatment of metastatic giant-cell tumor of bone in a 10-year-old girl,” Journal of Clinical Oncology, vol. 31, no. 12, pp. e200–e202, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. H. C. Lee, H.-C. Joo, S. H. Lee et al., “Endovascular repair versus open repair for isolated descending thoracic aortic aneurysm,” Yonsei Medical Journal, vol. 56, no. 4, pp. 904–912, 2015. View at Publisher · View at Google Scholar
  11. G. Eid-Lidt, J. Gaspar Hernández, H. González-Pacheco et al., “Complicated acute aortic syndromes affecting the descending thoracic aorta: endovascular treatment compared with open repair,” Clinical Cardiology, 2015. View at Publisher · View at Google Scholar